These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 2456512

  • 1. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB.
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients.
    Kaplan CS, Petersen EA, Icenogle TB, Copeland JG, Villar HV, Sampliner R, Minnich L, Ray CG.
    Arch Intern Med; 1989 Sep; 149(9):2095-100. PubMed ID: 2549896
    [Abstract] [Full Text] [Related]

  • 3. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [Abstract] [Full Text] [Related]

  • 4. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
    Icenogle TB, Peterson E, Ray G, Minnich L, Copeland JG.
    J Heart Transplant; 1987 Sep; 6(4):199-203. PubMed ID: 2822880
    [Abstract] [Full Text] [Related]

  • 5. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
    Novick RJ, Menkis AH, McKenzie FN, Reid KR, Ahmad D.
    J Heart Transplant; 1990 Sep; 9(6):699-706. PubMed ID: 2177496
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus infection and survival in lung transplant recipients.
    Duncan AJ, Dummer JS, Paradis IL, Dauber JH, Yousem SA, Zenati MA, Kormos RL, Griffith BP.
    J Heart Lung Transplant; 1991 Sep; 10(5 Pt 1):638-44; discussion 645-6. PubMed ID: 1659899
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS, Verano AS, Levandowski RA.
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [Abstract] [Full Text] [Related]

  • 8. [The significance of cytomegalovirus infection in the period after a heart transplant].
    Manito N, Pérez JL, Roca J, Niubó J, Gausí C, Castells E.
    Rev Esp Cardiol; 1995 Jun; 48 Suppl 7():108-14. PubMed ID: 8775825
    [Abstract] [Full Text] [Related]

  • 9. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M, Czer LS, Pan SH, Aleksic I, Freimark D, Harasty DA, Admon D, Barath P, Blanche C, Trento A.
    J Heart Lung Transplant; 1995 Jun; 14(4):659-65. PubMed ID: 7578172
    [Abstract] [Full Text] [Related]

  • 10. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID, Syriopoulou VP, Chelioti H, Daikos GL, Stamatiades D, Kostakis A, Boletis JN.
    Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
    [Abstract] [Full Text] [Related]

  • 11. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Gluckman E, McMazeron, Keable H, Meletis J, Bombail D, Jolivet I, Huart JJ, Nebout T, Cavazzana M, De Castro H.
    Nouv Rev Fr Hematol (1978); 1987 Sep; 29(1):17-21. PubMed ID: 3035485
    [Abstract] [Full Text] [Related]

  • 12. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H, Flik J, Stangel W, Heigel R.
    Beitr Infusionsther; 1990 Sep; 26():33-6. PubMed ID: 1703866
    [Abstract] [Full Text] [Related]

  • 13. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP.
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [Abstract] [Full Text] [Related]

  • 14. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Dec; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T, Nampoory MR, Johny KV, Pacsa AS, Mini Abraham P, Nair MP, Abdel-Haleem M, Samhan M, Al-Mousawi M.
    Transplant Proc; 2004 Dec; 36(6):1847-9. PubMed ID: 15350495
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ, Busuttil RW.
    Transplantation; 2003 Jan 27; 75(2):229-33. PubMed ID: 12548129
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
    Thomas LD, Milstone AP, Miller GG, Loyd JE, Stephen Dummer J.
    Clin Transplant; 2009 Jan 27; 23(4):476-83. PubMed ID: 19453645
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus infections in heart and heart-lung transplant recipients.
    Wreghitt T.
    J Antimicrob Chemother; 1989 Jun 27; 23 Suppl E():49-60. PubMed ID: 2550412
    [Abstract] [Full Text] [Related]

  • 19. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K, Treska V.
    J Clin Virol; 2006 Jun 27; 36(2):146-51. PubMed ID: 16531113
    [Abstract] [Full Text] [Related]

  • 20. Acyclovir prophylaxis for cytomegalovirus disease in high-risk renal transplant recipients: is it effective?
    Goral S, Ynares C, Dummer S, Helderman JH.
    Kidney Int Suppl; 1996 Dec 27; 57():S62-5. PubMed ID: 8941924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.